Invivoscribe and Complete Genomics have announced a partnership aimed at developing and commercializing biomarker tests on the latter’s next-generation sequencing (NGS) platforms. The collaboration, covering worldwide territories, focuses on oncology and cancer research. Based in California, Invivoscribe is specialized in precision diagnostics and reagents for hematologic malignancies and molecular diagnostics. Also based in California, Complete […]
A new COVID-19 Genomics UK Consortium has been created with support from the UK government to map how the novel coronavirus spreads and behaves by using whole-genome sequencing. The University of Liverpool is the newest member to join the consortium which is said to include the UK’s leading clinicians and scientists. The consortium backed by […]
Californian biotechnology startup Element Biosciences, which focuses on developing genomic sequencing solutions for research and diagnostic markets, has raised $80.3 million in a Series B financing round. The financing round saw the entry of new investors Fidelity Management & Research and JS Capital alongside participation from existing investors Foresite Capital and Venrock. The US biotechnology startup […]
